Showing results (51-60 of 148) with videos related to

Sort By:
Pageof 15
European Psychiatry : the Journal of the Association of European Psychiatrists|February 19, 2013
Is it worth assessing progress as early as week 2 to adapt antidepressive treatment strategy? Results from a study on agomelatine and a global meta-analysisP Gorwood, F Bayle, G Vaiva, et al.
L'Encephale|July 16, 2017
Follow-up study of patients treated with olanzapine pamoate in France in real-life treatment situationF Chartier, F Rouillon, L Berggren, et al.
L'Encephale|November 15, 2003
[Interest of the use of pindolol in the treatment of depression: review]G Brousse, A Schmitt, I Chereau, et al.
L'Encephale|June 4, 2013
[Current status and management of patients with bipolar disorder in France: the MONTRA survey]P-M Llorca, V Camus, P Courtet, et al.
Neurophysiologie Clinique = Clinical Neurophysiology|March 1, 1989
[Central effects of five beta-adrenergic receptor blockers in healthy volunteers: a quantitative EEG study]C Sabot, J C Pechadre, P Beudin, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|November 4, 2017
Validation of a four items version of the Functional Remission of General Schizophrenia scale (the mini-FROGS) to capture the functional benefits of clinical remissionJ Mallet, S Lancrenon, P-M Llorca, et al.
L'Encephale|April 2, 2013
[Evaluation of functional remission in schizophrenic disorder. The FROGS Scale]F Rouillon, F J Baylé, P Gorwood, et al.
L'Encephale|January 1, 1994
[Descriptive approach to latent forms of schizophrenia]B Rivet, T Bougerol, B Cura, et al.
L'Encephale|March 21, 2007
[Benzodiazepines and schizophrenia, a review of the literature]R Gaillard, A Ouanas, C Spadone, et al.
Revue Neurologique|August 18, 2009
[Assessment of hyper- and hypodopaminergic behaviors in Parkinson's disease]C Ardouin, I Chéreau, P-M Llorca, et al.
Pageof 15